This review summarizes the main advances made in the epidemiology, pathogen
esis, and medical treatment of gallstone disease in the past year. Whether
rapid weight reduction can precipitate gallstone formation is still debated
. Phospholipase A(2)-II seems to play an interesting role in the pathogenes
is of multiple cholesterol stone formation, and ursodeoxycholic acid may pa
rtially halt the formation of multiple cholesterol stones by mediating an a
nti-inflammatory effect on the gallbladder, Bacterial infections may contri
bute to gallstone formation, perhaps through secretion of biofilm, The comb
ination of ursodeoxycholic acid and simvastatin for the resolution and prev
ention of gallstones is promising, but larger studies are needed. (C) 1999
Lippincott Williams & Wilkins, Inc.